Search Results
You are looking at 1 - 1 of 1 items for
- Author: Y. Naito x
- Refine by access: All content x
Search for other papers by T. Tominaga in
Google Scholar
PubMed
Search for other papers by J. Fukata in
Google Scholar
PubMed
Search for other papers by Y. Naito in
Google Scholar
PubMed
Search for other papers by Y. Nakai in
Google Scholar
PubMed
Search for other papers by S. Funakoshi in
Google Scholar
PubMed
Search for other papers by N. Fujii in
Google Scholar
PubMed
Search for other papers by H. Imura in
Google Scholar
PubMed
ABSTRACT
We have examined the mechanism by which corticostatin-I (CS-I) acts to attenuate ACTH-induced steroidogenesis in rat adrenal cells. CS-I inhibited ACTH-induced corticosterone production in a dosedependent manner, without any effects on the basal corticosterone level in adrenal cells. When the cells were stimulated by 100 pg ACTH/ml, the minimum effective concentration of CS-I was 100 ng/ml, and 0.3–1.0 μg CS-I/ml produced a 50% reduction of the stimulated corticosterone production. The inhibitory effect of CS-I on ACTH-stimulated corticosterone production became apparent within 15 min of incubation, and the effect was reversed quickly by the removal of CS-I from the media. CS-I had no effect on angiotensin II-stimulated aldosterone production by adrenal zona glomerulosa cells. CS-I also did not affect cyclic AMP- or forskolin-stimulated corticosterone production. In an in-vitro binding study using 125I-labelled CS-I, CS-I showed considerable specific binding to rat adrenal cells, and the binding competed with ACTH in a dose-dependent manner. These experiments suggest that CS-I competes with ACTH on their binding sites and exerts an inhibitory effect on the adrenal cells.
Journal of Endocrinology (1990) 125, 287–292
